DrugPatentWatch Database Preview

Details for Patent: 8,192,756

Which drugs does patent 8,192,756 protect, and when does it expire?

Patent 8,192,756 protects GRALISE and is included in one NDA.

This patent has twenty-three patent family members in nine countries.

Summary for Patent: 8,192,756

Title:	Gastric retained gabapentin dosage form
Abstract:	A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
Inventor(s):	Berner; Bret (Half Moon Bay, CA), Hou; Sui Yuen Eddie (Foster City, CA), Gusler; Gloria M (Cupertino, CA)
Assignee:	Depomed, Inc. (Menlo Park, CA)
Application Number:	13/111,575
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,192,756
Patent Claim Types: see list of patent claims	Compound; Dosage form; Use;

Drugs Protected by US Patent 8,192,756

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Depomed Inc	GRALISE	gabapentin	TABLET;ORAL	022544-001	Jan 28, 2011	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA	➤ Sign Up
Depomed Inc	GRALISE	gabapentin	TABLET;ORAL	022544-002	Jan 28, 2011	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,192,756

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,333,991	Gastric retained gabapentin dosage form	➤ Sign Up
7,731,989	Gastric retained gabapentin dosage form	➤ Sign Up
7,438,927	Methods of treatment using a gastric retained gabapentin dosage	➤ Sign Up
8,252,332	Gastric retained gabapentin dosage form	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,192,756

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002348828	➤ Sign Up
Australia	2005267738	➤ Sign Up
Australia	2006332690	➤ Sign Up
Canada	2464322	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,192,756

For more information try a trial or see the plans and pricing